Requires DOBI to review hormone replacement therapy coverage.
This bill requires New Jersey's Department of Banking and Insurance (DOBI) to conduct a one-time confidential review of health insurance coverage for hormone replacement therapy (HRT). The review will examine how insurers administer HRT coverage under the "New Jersey Menopause Coverage Act" and whether there has been an aggregate increase in coverage since that law took effect. DOBI will analyze data on prior authorization and step therapy decisions for HRT, as well as other insurer-collected information, and must report its findings to the Legislature within six months. This review directly affects health insurance carriers (by requiring them to provide data) and DOBI (as the reviewing agency), but does not change current coverage requirements.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 24, 2026
Last action Feb 24, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Feb 24, 2026
Introduced
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Heather Simmons
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 4449
Scope: NJ
Hi! I can help you understand A 4449. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline